Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02510591
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2AH2 | 0.78 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2FHR | 0.78 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A | 2A75 | 0.78 | |
FSI | 5-(ACETYLAMINO)-2,6-ANHYDRO-3,5- DIDEOXY-3-FLUORONONONIC ACID | A,B | 2VK7 | 0.78 | |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8G | 0.73 | |
AMV | METHYL 2-(ACETYLAMINO)-3-O-[(1R)- 1-CARBOXYETHYL]-2-DEOXY-BETA-D- GLUCOPYRANOSIDE | A | 2J8F | 0.73 | |
AMN | 9-DEOXY-9-AMINO-2-O-METHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGJ | 0.84 | |
CNP | 2-PROPENYL-N-ACETYL-NEURAMIC ACID | A | 4SLI | 0.76 | |
GM2 | N-[(1S,2S)-2-HYDROXY-1-({[(2R,3R,4S,5S,6R)- 3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)TETRAHYDRO- 2H-PYRAN-2-YL]OXY}METHYL)OCTADECYL]OCTADECANAMIDE | A | 1GZP | 0.7 | |
ANA | 4-O-ACETYL-ALPHA-2-OMETHYL-5-N- ACETYL-ALPHA-D-NEURAMINIC ACID | A,B,C,D,E,F | 1HGI | 0.83 | |
NAU | 4,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDONONANOIC ACID | A,C | 1F7B | 0.72 | |
GSL | (2S,3R)-3-HYDROXY-2-(TETRADECANOYLAMINO)OCTADECYL ALPHA- D-GALACTOPYRANOSIDURONIC ACID | A | 2FIK | 0.73 | |
BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)- 5-METHYLHYDROXY-L-PROLINE-TAURINE | A | 1D0M | 0.71 | |
BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)- 5-METHYLHYDROXY-L-PROLINE-TAURINE | A | 1D0L | 0.71 | |
BLG | 4-O-(4-O-SULFONYL-N-ACETYLGLUCOSAMININYL)- 5-METHYLHYDROXY-L-PROLINE-TAURINE | A | 1SLY | 0.71 | |
NGC | 3,5-dideoxy-5-[(hydroxyacetyl)amino]- D-glycero-alpha-D-galacto-non-2- ulopyranosonic acid | A,B,C,D,E | 3DWP | 0.81 | |
NGC | 3,5-dideoxy-5-[(hydroxyacetyl)amino]- D-glycero-alpha-D-galacto-non-2- ulopyranosonic acid | A,B,C,D,E | 3DWQ | 0.81 | |
BUL | BULGECIN A | A | 1LMC | 0.71 | |
BUL | BULGECIN A | A | 1LSP | 0.71 | |
GM3 | N-{1-[(HEXOPYRANOSYLOXY)METHYL]- 2-HYDROXYNONADECYL}TETRACOSANAMIDE | A | 2BV7 | 0.7 | |
NCC | A,C,D | 1QWJ | 0.7 | ||
MLD | GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)- L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA | A,X | 2F2L | 0.7 | |
MLD | GLCNAC(BETA1-4)-MURNAC(1,6-ANHYDRO)- L-ALA-GAMMA-D-GLU-MESO-A2PM-D-ALA | A,B,C,D | 2CB3 | 0.7 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3I | 0.83 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 1KQR | 0.83 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGH | 0.83 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B | 2I2S | 0.83 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3J | 0.83 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A,B,C,D,E,F | 1HGE | 0.83 | |
MNA | 2-O-METHYL-5-N-ACETYL-ALPHA-D- NEURAMINIC ACID | A | 2P3K | 0.83 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A,B,C,D | 2APH | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A,P | 1TWQ | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | A | 1D0K | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | S | 9LYZ | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | E,S | 148L | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | D,K | 3CYQ | 0.71 | |
AMU | BETA-N-ACETYLMURAMIC ACID | U | 2AIZ | 0.71 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXV | 0.7 | |
MU2 | N-ACETYLMURAMYL-L-ALANYL-D-ISOGLUTAMINE | A | 2IXU | 0.7 | |
HMN | 2,4,6,7,8,9-HEXAHYDROXY-5-METHYLCARBOXAMIDO NONANOIC ACID | A,B,C,D | 1F73 | 0.73 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A | 1ZT4 | 0.71 | |
AGH | N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]- 2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE | A,C,E | 2PO6 | 0.71 | |
MUB | N-ACETYLMURAMIC ACID | L,N | 1WCO | 0.71 |